Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - OtherRevenue (Gross)
Ratios

Abeona Therapeutics (ABEO) Leases (2019 - 2025)

Historic Leases for Abeona Therapeutics (ABEO) over the last 7 years, with Q3 2025 value amounting to $4.1 million.

  • Abeona Therapeutics' Leases rose 783.85% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year increase of 783.85%. This contributed to the annual value of $3.6 million for FY2024, which is 2026.94% down from last year.
  • According to the latest figures from Q3 2025, Abeona Therapeutics' Leases is $4.1 million, which was up 783.85% from $4.1 million recorded in Q2 2025.
  • In the past 5 years, Abeona Therapeutics' Leases ranged from a high of $9.4 million in Q4 2021 and a low of $3.6 million during Q4 2024
  • For the 5-year period, Abeona Therapeutics' Leases averaged around $5.4 million, with its median value being $4.9 million (2023).
  • In the last 5 years, Abeona Therapeutics' Leases soared by 3371.73% in 2021 and then plummeted by 4330.53% in 2022.
  • Quarter analysis of 5 years shows Abeona Therapeutics' Leases stood at $9.4 million in 2021, then tumbled by 43.31% to $5.3 million in 2022, then fell by 16.43% to $4.5 million in 2023, then dropped by 20.27% to $3.6 million in 2024, then grew by 15.03% to $4.1 million in 2025.
  • Its Leases was $4.1 million in Q3 2025, compared to $4.1 million in Q2 2025 and $4.2 million in Q1 2025.